119 related articles for article (PubMed ID: 683011)
21. Somatostatin reduces posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus.
Kollind M; Adamson U; Lins PE
Acta Endocrinol (Copenh); 1988 Jun; 118(2):173-8. PubMed ID: 2898855
[TBL] [Abstract][Full Text] [Related]
22. [Effect of caerulein on blood glucose, serum insulin, glucagon, prolactin and growth hormone before and after oral glucose load in healthy volunteers and diabetic patients (author's transl)].
Landgraf R; Eversmann T; Landgraf-Leurs MM
Klin Wochenschr; 1981 Jun; 59(11):539-43. PubMed ID: 7021992
[TBL] [Abstract][Full Text] [Related]
23. Insulin patterns prior to and after onset of diabetes.
Danowski TS; Lombardo YB; Mendelsohn LV; Corredor DG; Morgan CR; Sabeh G
Metabolism; 1969 Sep; 18(9):731-40. PubMed ID: 5343864
[No Abstract] [Full Text] [Related]
24. Effect of a somatostatin analog on insulin requirement and hormone levels in 6 insulin-dependent juvenile-onset diabetics subjected to artificial pancreas.
Lenti G; Trovati M; Lorenzati R; Vitelli F; Tagliaferro V; Marocco A; Pagano G
Acta Diabetol Lat; 1980; 17(1):9-14. PubMed ID: 6106342
[TBL] [Abstract][Full Text] [Related]
25. The effect of intravenous glucose infusion on the exercise-induced serum growth hormone rise in normals and juvenile diabetics.
Hansen AP
Scand J Clin Lab Invest; 1971 Oct; 28(2):195-205. PubMed ID: 5130107
[No Abstract] [Full Text] [Related]
26. Integrated concentration of growth hormone in juvenile-onset diabetes.
Hayford JT; Danney MM; Hendrix JA; Thompson RG
Diabetes; 1980 May; 29(5):391-8. PubMed ID: 6991330
[TBL] [Abstract][Full Text] [Related]
27. Abnormalities of endogenous glucagon and insulin in unstable diabetes.
Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS
Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563
[TBL] [Abstract][Full Text] [Related]
28. Effect of bromocriptine on maturity onset diabetes.
Barnett AH; Chapman C; Gailer K; Hayter CJ
Postgrad Med J; 1980 Jan; 56(651):11-4. PubMed ID: 6992131
[TBL] [Abstract][Full Text] [Related]
29. Somatostatin--clinical implications.
Ciba Found Symp; 1976; 41():313-50. PubMed ID: 780078
[No Abstract] [Full Text] [Related]
30. Clinical evaluation of somatostatin as a potential ajunct to insulin in the management of diabetes mellitus.
Gerich JE; Schultz TA; Lewis SB; Karam JH
Diabetologia; 1977 Sep; 13(5):537-44. PubMed ID: 908478
[TBL] [Abstract][Full Text] [Related]
31. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes.
Yamamoto T; Raskin P; Aydin I; Unger R
Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698
[TBL] [Abstract][Full Text] [Related]
32. Inappropriate counter-regulatory hormone levels in insulin treated diabetes.
Danowski TS; Fisher ER; Kozak W; Bahl VK; Stephan T; Nolan S; Ahmad U
Behav Neuropsychiatry; 1976 Apr-1977 Mar; 8(1-12):6-15. PubMed ID: 1052263
[TBL] [Abstract][Full Text] [Related]
33. Biphasic effect of somatostatin on oral glucose tolerance in maturity-onset diabetes.
Tamborlane WV; Sherwin RS; Hendler R; Felig P
Metabolism; 1978 Jul; 27(7):849-53. PubMed ID: 661568
[TBL] [Abstract][Full Text] [Related]
34. High 24-hour level of serum growth hormone in juvenile diabetics.
Johansen K; Hansen AP
Br Med J; 1969 May; 2(5653):356-7. PubMed ID: 5768463
[TBL] [Abstract][Full Text] [Related]
35. Circulating platelet aggregates induced by somatostatin in insulin-dependent diabetic subjects.
Coppola L; Giugliano D; Tirelli A; Misso L; Sgambato S; D'Onofrio F
Diabete Metab; 1980 Dec; 6(4):245-9. PubMed ID: 6110570
[TBL] [Abstract][Full Text] [Related]
36. [Glucagon, growth hormone, and cortisol response to insulin-induced hypoglycemia in insulin-dependent diabetics (IDD) without autonomic neuropathy (author's transl)].
Drost H; Grüneklee D; Kley HK; Wiegelmann W; Krüskemper HL; Gries FA
Klin Wochenschr; 1980 Nov; 58(21):1197-205. PubMed ID: 7005532
[TBL] [Abstract][Full Text] [Related]
37. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.
Gerich JE; Lorenzi M; Schneider V; Karam JH; Rivier J; Guillemin R; Forsham PH
N Engl J Med; 1974 Sep; 291(11):544-7. PubMed ID: 4604408
[No Abstract] [Full Text] [Related]
38. Renin, growth hormone and insulin in hemodialyzed uremic diabetics.
Avram MM
Artif Organs; 1978 Nov; 2(4):382-5. PubMed ID: 743011
[TBL] [Abstract][Full Text] [Related]
39. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
Hansen AP; Christensen SE; Lundbaek K
Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics.
Gerich JE; Lorenzi M; Schneider V; Kwan CW; Karam JH; Guillemin R; Forsham PH
Diabetes; 1974 Nov; 23(11):876-80. PubMed ID: 4430415
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
